• Mashup Score: 5

    In discussion with Dr. Sapna Patel, Associate Professor, Director of the Uveal Melanoma, and Melanoma Fellowship Program Director at the MD Anderson Cancer Center we discuss how to treat Cutaneous Melanoma and important nuances from Community Oncology perspective. – Management of Stage 0/IA melanoma – where management is mainly surgery – Who is the most […]

    Tweet Tweets with this article
    • w/@DrSapnaPatel we🗣️SoC for #Melanoma & key📝 to focus on in the community: - Adj IO Vs BRAF-MEKi - Switch Rx - #CTLA4 Full discussion: - https://t.co/dfFPLFjNcg - Also on the “Oncology Brothers” podcast #MedTwitter #OncTwitter #OncEd #Oncology @CureMelanoma @SWOG https://t.co/dPrnwhC2pL

  • Mashup Score: 22

    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…

    Tweet Tweets with this article
    • w/ @CathyEngMD, we 🗣 the Rx algorithm for #ColonCancer and the pending #Fruquintinib approval. Full Int: - https://t.co/LNQinz3t9O - Also on the “Oncology Brothers” podcast 🎙️ @OncoAlert @GIcancerDoc #gism @HemOncFellows @VUMCHemOnc #crcsm #OncTwitter #MedTwitter #OncEd https://t.co/WrciRcEML0

  • Mashup Score: 4

    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…

    Tweet Tweets with this article
    • w/ @DrGattiMays, we 🗣 the Rx algorithm for HR+ breast ca and the recent approvals. Full Int: - https://t.co/J8XmXnf2ti - Also on “Oncology Brothers” 🎙 @PTarantinoMD @JAMouabbi and @DrGattiMays 🙏🏽 for this #breastcancer series! #bcsm #MedTwitter #OncTwitter #OncEd #MedEd https://t.co/DzcCGVSLQZ

  • Mashup Score: 7

    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…

    Tweet Tweets with this article
    • @CharuAggarwalMD walks us through the Rx algorithm for #LungCancer Discussions w/@DrJNaidoo and @esinghimd to follow soon. Full Int: - https://t.co/UNmc27JvEb - Also on “Oncology Brothers” 🎙 #lcsm #MedTwitter #OncEd @OncoAlert #OncTwitter *Adj Pembro was✅a few days after* https://t.co/UIZIXAQbLs

  • Mashup Score: 8

    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…

    Tweet Tweets with this article
    • To reiterate the SoC for #SmallCell #LungCancer, @Latinamd walks us through the Rx algorithm. Discussions w/@CharuAggarwalMD and @esinghimd to follow soon. Full Int: - https://t.co/1V7d9XMdyQ - Also on “Oncology Brothers” 🎙 #lcsm #MedTwitter #OncEd @OncoAlert #OncTwitter https://t.co/upr61Pcv21

  • Mashup Score: 11

    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…

    Tweet Tweets with this article
    • Our conversation w/ @GIcancerDoc on #MOUNTAINEER: #Tucatinib + #Trastuzumab in Her2+ met #ColorectalCancer Full Int: - https://t.co/oT4KBpWayU - Also on “Oncology Brothers”🎙 #OncJC #MedTwitter #crcsm #OncEd @pashtoonkasi @VivekSubbiah @marklewismd @weldeiry #oncology #gism https://t.co/lPujwmnXx2

  • Mashup Score: 9

    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…

    Tweet Tweets with this article
    • Highlights @ASCO #GU23 w/@PGrivasMDPhD - Triple Rx & PARPi #prostatecancer - Adj Nivo & EV/Pembro #Bladder Ca - What’s next in #KidneyCancer? Full Int: - https://t.co/XNS9XsP7Xe - Also on “Oncology Brothers”🎙 @neerajaiims #OncEd #MedTwitter #gusm #oncology @apolo_andrea https://t.co/ktZ9vE1jf4

  • Mashup Score: 16

    Your PrivacyASCO is committed to transparency regarding our websites and the ways we process data. When you visit our site, we may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences, your location, or your device and is mostly used to make the site work as you expect it to and to personalize your web experience with…

    Tweet Tweets with this article
    • Day 1 #GU23 #ProstateCacer Highlights #CommunityOncology 1. #TALAPRO2: mCRPC PARPi 1L @neerajaiims  2. #TRITON3: mCRPC PARPi 2L @AlanBryce9  3. #ARASENS update Dara+Doce 1L 4. #PROPEL update PARPi 1L https://t.co/ma9PAah1Jm @ASCO #OncEd #MedEd @OncoAlert #GUSM #MedTwitter

  • Mashup Score: 9

    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and…

    Tweet Tweets with this article
    • With just a week to go for #GU23, @neerajaiims walks us through this Rx algorithm to reiterate the current SoC for #prostatecancer Full Int: - https://t.co/C0gVK1Ue9x - Also on the “Oncology Brothers” podcast #gusm #MedTwitter #OncEd #MedEd #oncology @OncoAlert #onctwitter https://t.co/Ws2CX6AqyG